To examine a potential role of MAP4Ks in ALS-hiMNs, we first tested another chemical inhibitor, PF6260933 (designated as MAP4Ki), an HGK-specific inhibitor but also potently inhibiting MINK1 and TNIK [35]. Here, MAP4K4 is linked to amyotrophic lateral sclerosis.